
Science Resources RSS Feeds
|
 |
 |
 |
UV lotion lights the way to cleaner facilities
May 12, 2008
A team of Canadian scientists using a lotion which glows under ultraviolet light have shown that up to a third of patient toilets are not properly cleaned. Their findings, published in BioMed Central's journal, BMC Infectious Diseases, also show that spores from the nasty bacteria Clostridium difficile (C. difficile) linger in the loo even when it has been thoroughly wiped down. Michelle Alfa and a team of scientists from Manitoba, Canada investigated the spread of so-called superbugs in hospitals. Hospital patients are thought to catch bugs like vancomycin resistant Enterococci (VRE), methicillin resistant Staphylococcus aureus (MRSA) and C. difficile because they are not eradicated from the hospital environment. These bugs may be transferred between patients through cross-contamination in the bathroom.
"Various studies have looked at the most effective cleaning agents, but none of these studies considered whether housekeeping staff were actually cleaning the toilets properly," says Alfa. "It is impossible to assess the effectiveness of any action against these bacteria unless you can be sure that cleaners comply with protocols."
Alfa's toilet inspectors smeared the UV lotion under the seats of 20 toilets and commodes being used by patients with diarrhoea at a hospital in Winnipeg. Seven of these patients had C. difficile infection, while 13 others did not. The toilets and commodes were tested every weekday for six months and checked using UV light to determine how well they had been cleaned. In addition, samples were taken from toilet surfaces to determine whether C difficile spores were present.
The UV marker revealed that the commodes for the seven patients isolated with C. difficle infections had not been properly cleaned 72% of the time. The toilets fared slightly better, with half of the samples taken showing no residual UV lotion after cleaning. The 13 patients not on isolation had much cleaner toilets, with only 14% glowing brightly under UV light. Further assessments showed that differences in toilet cleaning were "ward dependent" and since specific cleaners work on different wards, the results likely reflect characteristics of the individual cleaning staff.
More worryingly, C. difficle was still detected in 40% of samples taken from the cleanest toilets (i.e. those with no detectable UV marker). "This suggests that both the physical cleaning action as well as the disinfectant/cleaning agent were ineffective for killing and/or removing C. difficile from toilets," notes Alfa.
"Our data suggest that without an agent with some activity against C. difficile spores the physical action of cleaning alone cannot be relied upon to effectively eradicate this organism from the toilets of patients who are shedding this type of spore. Nevertheless, we would still recommend that monitoring with a UV marker becomes a routine part of a hospital's housekeeping quality assurance programme.
BioMed Central
|
 |
Related Clostridium Difficile Current Events and Clostridium Difficile News Articles Clostridium Difficile Current Events and Clostridium Difficile News RSS Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases.
Deadly stomach infection rising in community settings, Mayo Clinic study finds Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings.
Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says Healthy eating, not supplements, is the best way to keep the good bacteria in your gut healthy, says a dietitian and researcher.
Structure of antibiotic ramoplanin reveals promising mechanism With the "last resort" antibiotic Vancomycin now plagued by the first signs of bacterial resistance, a scientific collaboration centered at Duke University has identified how a candidate successor antibiotic known as Ramoplanin A2 can kill pathogenic bacteria by interrupting how they form their cell membranes.
Antibiotics take toll on beneficial microbes in gut It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance.
Newly discovered reactions from an old drug may lead to new antibiotics A mineral found at health food stores could be the key to developing a new line of antibiotics for bacteria that commonly cause diarrhea, tooth decay and, in some severe cases, death.
Doctors identify patients at high risk of C. difficile Doctors have developed and validated a clinical prediction rule for recurrent Clostridium difficile (C. difficile) infection that was simple, reliable and accurate, and can be used to identify high-risk patients most likely to benefit from measures to prevent recurrence. Their findings appear in a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Hospital infection control strategies for antibiotic-resistant organisms Hand-washing, a clean environment, appropriate infection barriers and early identification of patients at high risk of colonization with a transmissible microorganism remain the essential measures to prevent and control infection.
What makes C-Diff superbug deadly? A major breakthrough about the potentially deadly superbug Clostridium difficile (C-diff) could lead to new ways to combat the bacterium, according to a study to be published March 1 in the journal Nature.
Monash scientists debug superbug An international team of scientists, led by Monash University researchers, has uncovered the workings of a superbug that kills elderly hospital patients worldwide - a discovery that has the potential to save lives and health care systems billions of dollars each year. More Clostridium Difficile Current Events and Clostridium Difficile News Articles
|
 |

|
Bacteria for Breakfast: Probiotics for Good Health
by Kelly Dowhower Karpa, PhD, RPh (Author)
Although in Western society the beneficial aspects of bacteria have been increasingly minimized, we actually need bacteria in our digestive tracts for good health. This resource explains, to laymen and physicians, how probiotics support immune function, prevent urogenital infections, and maintain good gastrintestinal health.
|
|
|
Clostridium Difficile Test (25 per Pack)
by Marion Scientific
A 20 minute latex agglutination test for C. difficile associated diarrhea, 5 minutes hands on time, requires no instrument, excellent screening tes for stool specimenst, sensitivity found to be from 92 to 95%, negative predictive value 97 to 98%, controls included, performs 25 patient tests.
|
![Giantmicrobes C. Diff Clostridium Difficile [Toy]](http://ecx.images-amazon.com/images/I/31yVmHilYPL._SL160_.jpg)
|
Giantmicrobes C. Diff Clostridium Difficile [Toy]
by Giantmicrobes
Giant Microbes are soft, cute, durable, well made, educational, and just a lot of fun too! Each 5-to-7 inch doll is accompanied by an image of the real microbe it represents, as well as information about the microbe. Give it up for C. Diff, hospital's notorious gangsta.
|

|
Meridian Immunocard Toxins A & B Kit, 50 Tests
by Meridian Bioscience
Features of the Meridian Immunocard Toxins A & B Kit: Membrane EIA single test for the qualitative detection of Clostridium difficile Toxins A and B in Stool Specimens. High sensitivity: both Toxin A and Toxin B are detected. Rapid detection: results in 15 minutes. No sample pre-treatment required. No reagent dilution required. Easy and single test procedure. Internal control of the procedure on each card. Kit Components: Test cards, specimen diluent, enzyme conjugate, positive control, wash reagent, substrate reagent, transfer pipettes. The product referenced on this detail page is sold be 50/bx.
|

|
Clostridium difficile (Current Topics in Microbiology and Immunology)
by K. Aktories (Editor), T.D. Wilkins (Editor)
Clostridium difficile has been recognized as the cause of a broad spectrum of enteric disease ranging from mild antibiotic-associated diarrhea to pseudomembranous colitis. This volume gives new insights into the microbiology, diagnostics and epidemiology of Clostridium difficile and describes recent strategies in treatment of diseases caused by this agent. Main parts of the volume are devoted to Clostridium difficile toxins A and B which are the major virulence factors. The molecular biology, biochemistry, pharmacology and cell biology of these toxins which are the prototypes of a new family of large clostridial cytotoxins is described in great detail. Clostridium difficile toxins act as glucosyltransferases to inactivate small GTP-binding proteins of the Rho family which are involved in...
|

|
Clostridium Difficile - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
by ICON Health Publications (Author)
In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so.
|
|
|
Fecal transfer cures relapsing C. diff infection.(GASTROENTEROLOGY)(clostridium difficile): An article from: Internal Medicine News
by Miriam E. Tucker (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2009. The length of the article is 985 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Fecal transfer cures relapsing C. diff infection.(GASTROENTEROLOGY)(clostridium difficile) Author: Miriam E. Tucker Publication: Internal Medicine News (Magazine/Journal) Date: January 1, 2009 Publisher: International Medical News Group Volume: 42 Issue: 1 Page: 24(1)
Distributed by Gale, a part of Cengage...
|
|
|
Clostridium difficile (Methods in Molecular Biology)
by Peter Mullany (Editor), Adam P. Roberts (Editor)
This book reviews the state of the art of methods available for the molecular analysis and investigation of virulence of the important human pathogen Clostridium difficile.
|
|
|
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.: An article from: Emerging Infectious Diseases
by Ed J. Kuijper (Author), Renate J. van den Berg (Author), Sylvia Debast (Author), Caroline E. Visser (Author), Dick Veenendaal (Author), Annet Troelstra (Author), Tjallie van der Kooi (Author), Susan van den Hof (Author), Daan W. Notermans (Author)
This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on May 1, 2006. The length of the article is 2714 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Author: Ed J. Kuijper Publication: Emerging Infectious Diseases (Magazine/Journal) Date: May 1, 2006 Publisher: Thomson Gale Volume: 12 Issue: 5 Page: 827(4)
Distributed by Thomson...
|
|
|
Search goes on for effective therapies to combat CDAD.(Infectious Diseases)(Clostridium difficile associated diarrhea): An article from: Family Practice News
by Kerri Wachter (Author)
This digital document is an article from Family Practice News, published by Thomson Gale on September 15, 2006. The length of the article is 1012 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Search goes on for effective therapies to combat CDAD.(Infectious Diseases)(Clostridium difficile associated diarrhea) Author: Kerri Wachter Publication: Family Practice News (Magazine/Journal) Date: September 15, 2006 Publisher: Thomson Gale Volume: 36 Issue: 18 Page: 27(1)
Distributed by Thomson...
|
|